Oestrogen inhibits human colonic motility by a non-genomic cell membrane receptor-dependent mechanism

British Journal of Surgery

Volumn 96, Issue 7, 2009, Pages 817-822

  Hogan, A M ^a,b   Kennelly, R ^a,b   Collins, D ^a,b   Baird, A W ^b   Winter, D C ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOSTIN C; ESTRADIOL; ESTROGEN; FULVESTRANT; MEMBRANE RECEPTOR;

ADULT; AGED; ARTICLE; COLON MOTILITY; CONTROLLED STUDY; DNA TRANSCRIPTION; DRUG INHIBITION; DRUG MECHANISM; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; PREGNANT WOMAN; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

AGED; CASE-CONTROL STUDIES; CELL MEMBRANE; COLON; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROTEIN SYNTHESIS INHIBITORS;

EID: 67650079039     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6612     Document Type: Article

References (42)

1. Rossier BC. Mechanisms of action of mineralocorticoid hormones. Endocr Res 1989; 15: 206-226.
2. Yang JZ, O'Flatharta C, Harvey BJ, Thomas W. Membrane ERalpha-dependent activation of PKCalpha in endometrial cancer cells by estradiol. Steroids 2008; 73: 1110-1122.
3. Maguire D, MacNamara B, Cuffe JE, Winter D, Doolan CM, Urbach V. Rapid responses to aldosterone in human distal colon. Steroids 1999; 64: 51-63.
4. Doolan CM, Harvey BJ. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J Biol Chem1996; 271: 8763-8767.
5. Doolan CM, Harvey BJ. Rapid effects of steroid hormones on free intracellular calcium in T84 colonic epithelial cells. Am J Physiol 1996; 271: C1935-C1941.
6. Gottipati S, Cammarata PR. Mitochondrial superoxide dismutase activation with 17 beta-estradiol-treated human lens epithelial cells. Mol Vis 2008; 14: 898-905.
7. Alonso A, González C. Relationship between non-genomic actions of estrogens and insulin resistance. Infect Disord Drug Targets 2008; 8: 48-51.
8. Heino TJ, Chagin AS, Sävendahl L. The novel estrogen receptor G-protein coupled receptor 30 is expressed in human bone. J Endocrinol 2008; 197: R1-R6.
9. Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 2007; 14: 153-167.
10. Winter DC, Taylor C, O'Sullivan G, Harvey BJ. Mitogenic effects of oestrogen mediated by a non-genomic receptor in human colon. Br J Surg 2000; 87: 1684-1689.
11. Levin ER. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 1999; 10: 374-377.
12. Pietras RJ, Szego CM. Specific binding sites for estrogen at the outer surfaces of isolated endometrial cells. Nature 1977; 269: 69-72.
13. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha located in caveolae. Biochem Biophys Res Commun 1999; 263: 257-262.
14. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
15. Watson CS. Signaling themes shared between peptide and steroid hormones at the plasma membrane. Sci STKE 1999; 12: PE1.
16. Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008; 41: 263-275.
17. Muchekehu RW, Harvey BJ. Estradiol rapidly induces the translocation and activation of the intermediate conductance calcium activated potassium channel in human eccrine sweat gland cells. Steroids 2008; 74: 212-217.
18. Roepke TA, Xue C, Bosch MA, Scanlan TS, Kelly MJ, Rønnekleiv OK. Genes associated with membrane-initiated signaling of estrogen and energy homeostasis. Endocrinology 2008; 149: 6113-6124.
19. Fox EM, Andrade J, Shupnik MA. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 2008 (Epub ahead of print).
20. Cheng B, Song J, Zou Y, Wang Q, Lei Y, Zhu C et al. Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities. Int J Cardiol 2008 (Epub ahead of print).
21. 2+-mobilizing agonist ATP evoke acute NO synthesis via distinct pathways in an individual human vascular endothelium-derived cell. Am J Physiol Cell Physiol 2008; 294: C1531-C1541.
22. Alzamora R, Brown LR, Harvey BJ. Direct binding and activation of protein kinase C isoform by aldosterone and 17beta-estradiol. Mol Endocrinol 2007; 21: 2637-2680.
23. Heaton KW, Redvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool formation in the general population: a prospective study. Gut 1992; 33: 818-824.
24. Meier R, Beglinger C, Dedering JP, Meyer-Wyss B, Fumagalli M, Rowedder A et al. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil 1995; 7: 235-238.
25. Rees WD, Rhodes J. Altered bowel habit and menstruation. Lancet 1976; 1: 475.
26. Wald A, Van Thiel DH, Hoechestetter L, Gavaler JS, Egler KM, Verm R et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80: 1497-1500.
27. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol 1998; 93: 1867-1872.
28. Lawson M, Kern F Jr, Everson GT. Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology 1985; 89: 996-999.
29. Payne S. Sex, gender, and irritable bowel syndrome: making the connections. Gend Med 2004; 1: 18-28.
30. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC et al. Effect of estrogen therapy on gallbladder disease. JAMA 2005; 293: 330-339.
31. Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992; 21: 751-776.
32. Salom JB, Burguete MC, Pérez-Asensio FJ, Centeno JM, Torregrosa G. Acute relaxant effects of 17-beta-estradiol through non-genomic mechanisms in rabbit carotid artery. Steroids 2002; 67: 339-346.
33. Crone JK, Burnett AL, Chamness SL, Strandberg JD, Chang TS. Neuronal nitric oxide synthase in the canine prostate: aging, sex steroid and pathological correlations. J Androl 1998; 19: 358-364.
34. Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003; 148: 281-292.
35. Pommier Y, Marchand C. Interfacial inhibitors of protein-nucleic acid interactions. Curr Med Chem Anticancer Agents 2005; 5: 421-429.
36. Taguchi Y, Koslowski M, Bodenner DL. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl Recept 2004; 2: 5.
37. Toft D, Gorski J. A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc Natl Acad Sci U S A 1966; 55: 1574-1581.
38. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996; 93: 5925-5930.
39. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008; 9: 385-391.
40. Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA. Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 2005; 26: 465-478.
41. Chia S, Gradishar W. Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor positive advanced breast cancer. Breast 2008; 17(Suppl 3): S16-S21.
42. Fields AP, Regala RP. Protein kinase C iota: human oncogene, prognostic marker and therapeutic target. Pharmacol Res 2007; 55: 487-497.